Search

Your search keyword '"SERRANO, JONATHAN"' showing total 127 results

Search Constraints

Start Over You searched for: Author "SERRANO, JONATHAN" Remove constraint Author: "SERRANO, JONATHAN" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
127 results on '"SERRANO, JONATHAN"'

Search Results

1. A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.

2. Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips

6. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma

8. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

9. Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.

10. Data from Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors

11. Supplementary Table 2 from Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors

12. Supplementary Table 1 from Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors

13. Sarcoma classification by DNA methylation profiling

14. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors

16. Data from Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

17. Supplementary Figures 1-15 from Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

18. Supplementary Tables S1 and S2 from Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

19. Supplementary Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

21. Supplementary Figure from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

22. Supplementary Figure from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

23. Supplementary Figures S1, S2 from Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

24. Supplementary Data from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

25. Supplementary Tables from Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma

26. Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

27. Supplementary Tables S1-S4 from Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

28. Supplementary Figures and Legends from Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma

29. Supplementary Figures and Tables from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

30. Data from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

31. Supplementary Figure Legends from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

32. Supplementary Materials and Methods from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

33. Data from Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma

34. Genomic patterns of malignant peripheral nerve sheath tumor (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA

35. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing

41. Financing new ideas : evidence from Kickstarter campaigns

42. Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas

43. DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

44. HGG-60. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma

45. Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA

46. Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

47. Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma

48. RECONTAR EN EDUCACIÓN BILINGÜE: NARRACIÓN, PRESENTACIÓN DEL DISCURSO Y OTRAS HABILIDADES ADQUIRIDAS.

49. LA MOVILIDAD VIRTUAL COMO OTRA FORMA DE HACER MOVILIDAD ESTUDIANTIL EN PROGRAMAS DE POSGRADO.

50. PATH-39. INTEGRATED MOLECULAR-MORPHOLOGICAL MENINGIOMA CLASSIFICATION: A MULTICENTER RETROSPECTIVE ANALYSIS, RETRO- AND PROSPECTIVELY VALIDATED

Catalog

Books, media, physical & digital resources